CME/CE
Your professional development is critical to the care of your patients. Stay on top of the latest treatments and information with ReachMD's CME activities. Our topics span cardiology, diabetes, oncology, women's health and more. And our CME library is continuously growing, every quarter.
241-255 of 1026
Cynthia Villarreal-Garza, MD, DSc
The Future of Oral SERDs: Combination Strategies
MinuteCE®The Future of Oral SERDs: Combination Strategies
Komal Jhaveri, MD, FACP
Future-Proofing in HAE: Advances in Long-term Prophylaxis to Prevent Attacks and Improve Quality of Life
CME/CEFuture-Proofing in HAE: Advances in Long-term Prophylaxis to Prevent Attacks and Improve Quality of Life
Marc A. Riedl, MD, MS
Breaking Down the Benchmarks: Pivotal Data on First-Line CDK4/6 Inhibitors
MinuteCE®Breaking Down the Benchmarks: Pivotal Data on First-Line CDK4/6 Inhibitors
Giuseppe Curigliano, MD, PhD
Routes Reconsidered: A Case-Based Debate in SERD Selection
MinuteCE®Routes Reconsidered: A Case-Based Debate in SERD Selection
Giuseppe Curigliano, MD, PhD
Komal Jhaveri, MD, FACP
Unmet Needs in Endocrine Therapy: Rethinking the HR+/HER2- mBC Treatment Roadmap
MinuteCE®Unmet Needs in Endocrine Therapy: Rethinking the HR+/HER2- mBC Treatment Roadmap
Komal Jhaveri, MD, FACP
- advertisement
Giuseppe Curigliano, MD, PhD
RSV in Infants and Young Children: Are You Taking It Seriously Enough?
CME/CERSV in Infants and Young Children: Are You Taking It Seriously Enough?
Tina Q. Tan, MD
Muscarinic Therapies as a Catalyst for Change: Addressing Clinical Inertia in Schizophrenia Care
CME/CEMuscarinic Therapies as a Catalyst for Change: Addressing Clinical Inertia in Schizophrenia Care
Jose Rubio, MD
A Clear Horizon in Plaque Psoriasis: An Update on Investigational Oral Therapies
CME/CEA Clear Horizon in Plaque Psoriasis: An Update on Investigational Oral Therapies
Linda Stein Gold, MD
April W. Armstrong, MD, MPH
IgAN Management Into Practice: Evolving Guidelines & Targeted Therapies
CME/CEIgAN Management Into Practice: Evolving Guidelines & Targeted Therapies
Jörg Latus, MD
Jürgen Floege, MD
Navigating CMV Post-Transplant: Perspectives on Complex Cases: A Clinical Forum®
CME/CENavigating CMV Post-Transplant: Perspectives on Complex Cases: A Clinical Forum®
Roy F. Chemaly, MD, MPH, FIDSA, FACP
Atul Humar, MD, FRCPC, FAST
- advertisement
Engaging Your Patient: Shared Decision-Making in HF With LVEF ≥40%
CME/CEEngaging Your Patient: Shared Decision-Making in HF With LVEF ≥40%
Scott Solomon, MD
Kathleen Moore, MD, MS
Joyce F. Liu, MD, MPH
Safety and Tolerability of CDH6-Directed Antibody-Drug Conjugates
MinuteCE®Safety and Tolerability of CDH6-Directed Antibody-Drug Conjugates
Kathleen Moore, MD, MS
